132 related articles for article (PubMed ID: 6471423)
1. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10].
Tajima M
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1211-6. PubMed ID: 6471423
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
Tsubaki K; Horiuchi A; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yonezawa T; Tsubakio T; Kawagoe H; Shinohara Y
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
Okuma K; Furuta I; Ota K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
[TBL] [Abstract][Full Text] [Related]
4. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
Mortensen SA; Aabo K; Jonsson T; Baandrup U
Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy].
Takimoto M; Sakurai T; Kodama K; Yokoi H; Suzuki Y; Enomoto K; Okada N
Gan To Kagaku Ryoho; 1982 Jan; 9(1):116-21. PubMed ID: 7184359
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyopathy and other chronic toxic effects induced in rabbits by doxorubicin and possible prevention by coenzyme Q10.
Domae N; Sawada H; Matsuyama E; Konishi T; Uchino H
Cancer Treat Rep; 1981; 65(1-2):79-91. PubMed ID: 7226168
[TBL] [Abstract][Full Text] [Related]
7. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
Dohmae N; Sawada H; Tashima M; Uchino H; Matsuyama E; Konishi T
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1009-28. PubMed ID: 541529
[No Abstract] [Full Text] [Related]
8. Possible prevention from the progression of cardiotoxicity in adriamycin-treated rabbits by coenzyme Q10.
Usui T; Ishikura H; Izumi Y; Konishi H; Dohmae N; Sawada H; Uchino H; Matsuda H; Konishi T
Toxicol Lett; 1982 Jun; 12(1):75-82. PubMed ID: 7112605
[TBL] [Abstract][Full Text] [Related]
9. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
Folkers K; Wolaniuk A
Drugs Exp Clin Res; 1985; 11(8):539-45. PubMed ID: 3836873
[TBL] [Abstract][Full Text] [Related]
10. [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss].
Akihama T; Nakamoto Y; Shindo T; Nakayama Y; Miura A
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2125-9. PubMed ID: 6354099
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
12. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
Wang SQ
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
[TBL] [Abstract][Full Text] [Related]
13. Prevention by coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats.
Choe JY; Combs AB; Folkers K
Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):199-202. PubMed ID: 441512
[TBL] [Abstract][Full Text] [Related]
14. [Chronic cardiotoxicity of adriamycin and the possible prevention by coenzyme Q10 in rabbits (author's transl)].
Sawada H; Tashima M; Donomae N; Eguchi T; Uehara N; Shirakawa S; Yamagishi M; Nakamura T; Uchino H; Konishi T; Okazaki H; Matsuyama E
Nihon Gan Chiryo Gakkai Shi; 1979 Apr; 14(2):143-51. PubMed ID: 448221
[No Abstract] [Full Text] [Related]
15. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
Cortes EP; Gupta M; Chou C; Amin VC; Folkers K
Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga C; Beretta G; Vigo PL; Lenaz GR; Pollini C; Bonadonna G; Canetta R; Castellani R; Villa E; Gallagher CG; von Melchner H; Hayat M; Ribaud P; De Wasch G; Mattsson W; Heinz R; Waldner R; Kolaric K; Buehner R; Ten Bokkel-Huyninck W; Perevodchikova NI; Manziuk LA; Senn HJ; Mayr AC
Cancer Treat Rep; 1979 May; 63(5):827-34. PubMed ID: 455324
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
Langsjoen PH; Vadhanavikit S; Folkers K
Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
[TBL] [Abstract][Full Text] [Related]
18. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
Okuma K; Furuta I; Ota K
Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations.
Taggart DP; Jenkins M; Hooper J; Hadjinikolas L; Kemp M; Hue D; Bennett G
Ann Thorac Surg; 1996 Mar; 61(3):829-33. PubMed ID: 8619701
[TBL] [Abstract][Full Text] [Related]
20. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
Svojgrová M; Slechtová J; Hůla J
Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
